Antje M. Wengner

Differential Mobilization of Subsets of Progenitor Cells from the Bone Marrow

Simon C. Pitchford, Rebecca C. Furze, Carla P. Jones et al. · Cell stem cell · 2009 · 284 citations · Full text

Life Sciences, Cell Biology, Hematology +16

The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation

Antje M. Wengner, Simon C. Pitchford, Rebecca C. Furze et al. · Blood · 2007 · 227 citations · Full text

Life Sciences, Immunology, Pathology +17

The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models

Antje M. Wengner, Gerhard Siemeister, Ulrich Lücking et al. · Molecular Cancer Therapeutics · 2019 · 210 citations

Medicine, Molecular Biology, Oncology +17

The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (<i>R</i>)‐<i>S</i>‐Cyclopropyl‐<i>S</i>‐(4‐{[4‐{[(1<i>R</i>,2<i>R</i>)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer

Ulrich Lücking, Rolf Jautelat, Martin Krüger et al. · ChemMedChem · 2013 · 178 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application

Gerhard Siemeister, Ulrich Lücking, Antje M. Wengner et al. · Molecular Cancer Therapeutics · 2012 · 157 citations · Full text

Medicine, Oncology, Pharmacology +17